1. Home
  2. Pharma & Healthcare
  3. Global Nanopharmaceuticals Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Nanopharmaceuticals Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 154 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Nanopharmaceuticals market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Nanopharmaceuticals market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Nanopharmaceuticals in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension

Market Snapshot, By Application
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Stryker
Selecta Biosciences
Sanofi
Samyang Biopharm
Roche
Pfizer
Par Pharmaceutical
OSI Pharmaceuticals
Novavax
Novartis
Navidea Biopharmaceuticals
Mitsubishi Pharma
Merck
Lummy
Kaken Pharmaceutical
Kadmon Pharmaceuticals
Johnson & Johnson
GlaxoSmithKline
Gilead Sciences
Eli Lilly
Cerulean Pharma
Celgene
Astrazeneca
Abbott

The study objectives of this report are:
To study and analyze the global Nanopharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Nanopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Nanopharmaceuticals manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nanopharmaceuticals market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Nanopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nanopharmaceuticals are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Nanopharmaceuticals Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Nanopharmaceuticals Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Nanopharmaceuticals

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Nanopharmaceuticals Sales Channel and Distributors Analysis
3.3.1 Nanopharmaceuticals Sales Channel
3.3.2 Nanopharmaceuticals Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Nanopharmaceuticals Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Nanopharmaceuticals Type Introduction
4.1.1 Liposomes
4.1.2 Polymeric Micelles
4.1.3 Solid Lipid Nanoparticles
4.1.4 Microemulsion and Nnanoemulsion
4.1.5 Nanosuspension
4.2 Global Nanopharmaceuticals Sales by Type 2016-2021
4.3 Global Nanopharmaceuticals Revenue by Type 2016-2021
4.4 Global Nanopharmaceuticals Price by Type 2016-2021

5 Market Segment: by Application
5.1 Nanopharmaceuticals Type Introduction
5.1.1 Cancer and Tumor
5.1.2 Autoimmune Disorders
5.1.3 Inflammation
5.1.3 Others
5.2 Global Nanopharmaceuticals Sales by Application 2016-2021
5.3 Global Nanopharmaceuticals Revenue by Application 2016-2021
5.4 Global Nanopharmaceuticals Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Nanopharmaceuticals Market by Region
6.1.1 Global Nanopharmaceuticals Sales by Regions
6.1.2 Global Nanopharmaceuticals Revenue by Regions
6.2 North America Nanopharmaceuticals Market 2016-2021
6.3 Europe Nanopharmaceuticals Market 2016-2021
6.4 Asia Pacific Nanopharmaceuticals Market 2016-2021
6.5 South America Nanopharmaceuticals Market 2016-2021
6.6 Middle East and Africa Nanopharmaceuticals Market 2016-2021

7 North America
7.1 North America Nanopharmaceuticals Market by Country 2016-2021
7.1.1 North America Nanopharmaceuticals Sales by Country
7.1.2 North America Nanopharmaceuticals Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Nanopharmaceuticals Market by Country 2016-2021
8.1.1 Europe Nanopharmaceuticals Sales by Country
8.1.2 Europe Nanopharmaceuticals Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Nanopharmaceuticals Market by Country 2016-2021
9.1.1 Asia Pacific Nanopharmaceuticals Sales by Country
9.1.2 Asia Pacific Nanopharmaceuticals Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Nanopharmaceuticals Market by Country 2016-2021
10.1.1 South America Nanopharmaceuticals Sales by Country
10.1.2 South America Nanopharmaceuticals Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Nanopharmaceuticals Market by Country 2016-2021
11.1.1 Middle East and Africa Nanopharmaceuticals Sales by Country
11.1.2 Middle East and Africa Nanopharmaceuticals Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Stryker
12.1.1 Stryker Company Information
12.1.2 Stryker Nanopharmaceuticals Product Portfolio, Specification and Application
12.1.3 Stryker Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Stryker Key Development
12.2 Selecta Biosciences
12.2.1 Selecta Biosciences Company Information
12.2.2 Selecta Biosciences Nanopharmaceuticals Product Portfolio, Specification and Application
12.2.3 Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Selecta Biosciences Key Development
12.3 Sanofi
12.3.1 Sanofi Company Information
12.3.2 Sanofi Nanopharmaceuticals Product Portfolio, Specification and Application
12.3.3 Sanofi Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Sanofi Key Development
12.4 Samyang Biopharm
12.4.1 Samyang Biopharm Company Information
12.4.2 Samyang Biopharm Nanopharmaceuticals Product Portfolio, Specification and Application
12.4.3 Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Samyang Biopharm Key Development
12.5 Roche
12.5.1 Roche Company Information
12.5.2 Roche Nanopharmaceuticals Product Portfolio, Specification and Application
12.5.3 Roche Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Roche Key Development
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Nanopharmaceuticals Product Portfolio, Specification and Application
12.6.3 Pfizer Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Pfizer Key Development
12.7 Par Pharmaceutical
12.7.1 Par Pharmaceutical Company Information
12.7.2 Par Pharmaceutical Nanopharmaceuticals Product Portfolio, Specification and Application
12.7.3 Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Pfizer Key Development
12.9 Novavax
12.9.1 Novavax Company Information
12.9.2 Novavax Nanopharmaceuticals Product Portfolio, Specification and Application
12.9.3 Novavax Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Novavax Key Development
12.8 OSI Pharmaceuticals
12.8.1 OSI Pharmaceuticals Company Information
12.8.2 OSI Pharmaceuticals Nanopharmaceuticals Product Portfolio, Specification and Application
12.8.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 OSI Pharmaceuticals Key Development
12.11 Navidea Biopharmaceuticals
12.11.1 Navidea Biopharmaceuticals Company Information
12.11.2 Navidea Biopharmaceuticals Nanopharmaceuticals Product Portfolio, Specification and Application
12.11.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Navidea Biopharmaceuticals Key Development
12.12 Mitsubishi Pharma
12.12.1 Mitsubishi Pharma Company Information
12.12.2 Mitsubishi Pharma Nanopharmaceuticals Product Portfolio, Specification and Application
12.12.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Mitsubishi Pharma Key Development
12.13 Merck
12.13.1 Merck Company Information
12.13.2 Merck Nanopharmaceuticals Product Portfolio, Specification and Application
12.13.3 Merck Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Merck Key Development
12.14 Lummy
12.14.1 Lummy Company Information
12.14.2 Lummy Nanopharmaceuticals Product Portfolio, Specification and Application
12.14.3 Lummy Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Lummy Key Development
12.15 Kaken Pharmaceutical
12.15.1 Kaken Pharmaceutical Company Information
12.15.2 Kaken Pharmaceutical Nanopharmaceuticals Product Portfolio, Specification and Application
12.15.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Kaken Pharmaceutical Key Development
12.17 Johnson & Johnson
12.18 GlaxoSmithKline
12.19 Gilead Sciences
12.20 Eli Lilly
12.21 Cerulean Pharma
12.22 Celgene
12.23 Astrazeneca
12.24 Abbott

13 Global Nanopharmaceuticals Market Forecast by Region by Type and by Application
13.1 Global Nanopharmaceuticals Sales, Revenue Forecast 2022-2027
13.2 Global Nanopharmaceuticals Forecast by Regions
13.2.1 Global Nanopharmaceuticals Sales Forecast by Region 2022-2027
13.2.2 Global Nanopharmaceuticals Revenue Forecast by Region 2022-2027
13.3 Global Nanopharmaceuticals Forecast by Type
13.3.1 Global Nanopharmaceuticals Sales Forecast by Type 2022-2027
13.3.2 Global Nanopharmaceuticals Revenue Forecast by Type 2022-2027
13.3.3 Global Nanopharmaceuticals Price Forecast by Type 2022-2027
13.4 Global Nanopharmaceuticals Forecast by Application
13.4.1 Global Nanopharmaceuticals Sales Forecast by Application 2022-2027
13.4.2 Global Nanopharmaceuticals Revenue Forecast by Application 2022-2027
13.4.3 Global Nanopharmaceuticals Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Nanopharmaceuticals Production Specifications
Table 2: Drivers in Nanopharmaceuticals Market
Table 3: Restraints Nanopharmaceuticals Market
Table 4: Opportunity in Nanopharmaceuticals Market
Table 5: Comparion of Alternative and Nanopharmaceuticals
Table 6: Nanopharmaceuticals Raw Materials Key Suppliers List
Table 7: Nanopharmaceuticals Distributors List
Table 8: Nanopharmaceuticals Major Buyers in Application One
Table 9: Nanopharmaceuticals Major Buyers in Application Two
Table 10: Nanopharmaceuticals Major Buyers in Application Three
Table 11: Global Nanopharmaceuticals Sales (K Units) by Type 2016-2021
Table 12: Global Nanopharmaceuticals Sales Market Share by Type 2016-2021
Table 13: Global Nanopharmaceuticals Revenue (Million USD) by Type 2016-2021
Table 14: Global Nanopharmaceuticals Revenue Market Share by Type 2016-2021
Table 15: Global Nanopharmaceuticals Price by Type 2016-2021
Table 16: Global Nanopharmaceuticals Sales (K Units) by Application 2016-2021
Table 17: Global Nanopharmaceuticals Sales Market Share by Application 2016-2021
Table 18: Global Nanopharmaceuticals Revenue (Million USD) by Application 2016-2021
Table 19: Global Nanopharmaceuticals Revenue Market Share by Application 2016-2021
Table 20: Global Nanopharmaceuticals Price by Application 2016-2021
Table 21: Global Nanopharmaceuticals Sales (K Units) by Region 2016-2021
Table 22: Global Nanopharmaceuticals Sales Market Share by Region 2016-2021
Table 23: Global Nanopharmaceuticals Revenue (Million USD) by Region 2016-2021
Table 24: Global Nanopharmaceuticals Revenue Market Share by Region 2016-2021
Table 25: North America Nanopharmaceuticals Sales (K Units) by Country 2016-2021
Table 26: North America Nanopharmaceuticals Sales Market Share by Country 2016-2021
Table 27: North America Nanopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 28: North America Nanopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 29: Europe Nanopharmaceuticals Sales (K Units) by Country 2016-2021
Table 30: Europe Nanopharmaceuticals Sales Market Share by Country 2016-2021
Table 31: Europe Nanopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 32: Europe Nanopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Nanopharmaceuticals Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Nanopharmaceuticals Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Nanopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Nanopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 37: South America Nanopharmaceuticals Sales (K Units) by Country 2016-2021
Table 38: South America Nanopharmaceuticals Sales Market Share by Country 2016-2021
Table 39: South America Nanopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 40: South America Nanopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Nanopharmaceuticals Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Nanopharmaceuticals Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Nanopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Nanopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 45 Stryker Company Information
Table 46 Stryker Nanopharmaceuticals Product Portfolio, Specification and Application
Table 47 Stryker Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Selecta Biosciences Company Information
Table 49 Selecta Biosciences Nanopharmaceuticals Product Portfolio, Specification and Application
Table 50 Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Sanofi Company Information
Table 52 Sanofi Nanopharmaceuticals Product Portfolio, Specification and Application
Table 53 Sanofi Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Samyang Biopharm Company Information
Table 55 Samyang Biopharm Nanopharmaceuticals Product Portfolio, Specification and Application
Table 56 Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Roche Company Information
Table 58 Roche Nanopharmaceuticals Product Portfolio, Specification and Application
Table 59 Roche Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Pfizer Company Information
Table 61 Pfizer Nanopharmaceuticals Product Portfolio, Specification and Application
Table 62 Pfizer Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Par Pharmaceutical Company Information
Table 64 Par Pharmaceutical Nanopharmaceuticals Product Portfolio, Specification and Application
Table 65 Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 OSI Pharmaceuticals Company Information
Table 67 OSI Pharmaceuticals Nanopharmaceuticals Product Portfolio, Specification and Application
Table 68 OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Novavax Company Information
Table 70 Novavax Nanopharmaceuticals Product Portfolio, Specification and Application
Table 71 Novavax Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Nanopharmaceuticals Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Nanopharmaceuticals Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Nanopharmaceuticals Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Nanopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Nanopharmaceuticals Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Nanopharmaceuticals Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Nanopharmaceuticals Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Nanopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Nanopharmaceuticals Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Nanopharmaceuticals Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Nanopharmaceuticals Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Nanopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Nanopharmaceuticals Picture
Figure 2: Global Nanopharmaceuticals Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Nanopharmaceuticals Supply Chain Analysis
Figure 5: Nanopharmaceuticals Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Liposomes
Figure 7: Product Picture of Polymeric Micelles
Figure 8: Global Nanopharmaceuticals Sales Market Share by Type, 2020
Figure 9: Global Nanopharmaceuticals Revenue Market Share by Type, 2020
Figure 10: Nanopharmaceuticals in Cancer and Tumor
Figure 11: Global Nanopharmaceuticals Market: Cancer and Tumor 2016-2021
Figure 12: Nanopharmaceuticals in Autoimmune Disorders
Figure 13: Global Nanopharmaceuticals Market: Autoimmune Disorders 2016-2021
Figure 14: Global Nanopharmaceuticals Sales Market Share by Application, 2020
Figure 15: Global Nanopharmaceuticals Revenue Market Share by Application, 2020
Figure 16: Global Nanopharmaceuticals Sales Market Share by Region 2016-2021
Figure 17: Global Nanopharmaceuticals Revenue Market Share by Region 2016-2021
Figure 18: North America Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 19: North America Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 20: Europe Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 21: Europe Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 24: South America Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 25: South America Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 28: North America Nanopharmaceuticals Sales Market Share by Country, 2020
Figure 29: North America Nanopharmaceuticals Revenue Market Share by Country, 2020
Figure 30: United States Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 31: United States Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 32: Canada Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 33: Canada Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 35: Mexico Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 36: Europe Nanopharmaceuticals Sales Market Share by Country, 2020
Figure 37: Europe Nanopharmaceuticals Revenue Market Share by Country, 2020
Figure 38: Germany Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 39: Germany Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 40: France Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 41: France Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 42: UK Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 43: UK Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 44: Italy Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 45: Italy Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 46: Russia Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 46: Russia Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 47: Spain Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 48: Spain Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Nanopharmaceuticals Sales Market Share by Country, 2020
Figure 50: Asia Pacific Nanopharmaceuticals Revenue Market Share by Country, 2020
Figure 51: China Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 52: China Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 53: Japan Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 54: Japan Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 55: Korea Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 56: Korea Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 59: India Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 60: India Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 61: Australia Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 62: Australia Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 63: South America Nanopharmaceuticals Sales Market Share by Country, 2020
Figure 64: South America Nanopharmaceuticals Revenue Market Share by Country, 2020
Figure 65: Brazil Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 66: Brazil Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 68: Argentina Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 70: Colombia Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Nanopharmaceuticals Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Nanopharmaceuticals Revenue Market Share by Country, 2020
Figure 73: Turkey Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 74: Turkey Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Nanopharmaceuticals Sales (K Units) Status 2016-2021
Figure 78: South Africa Nanopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 79: Stryker Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 80: Selecta Biosciences Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 81: Sanofi Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 82: Samyang Biopharm Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 83: Roche Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 84: Pfizer Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 85: Par Pharmaceutical Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 86: OSI Pharmaceuticals Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 87: Novavax Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 88: Novartis Nanopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 89: Global Nanopharmaceuticals Sales (K Units) Forecast (2022-2027)
Figure 90: Global Nanopharmaceuticals Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets